Effect of finerenone on nephrotic syndrome in patients with diabetic kidney disease.

Moreover, while the eGFR decline slope showed a tendency to decrease with finerenone treatment, this change did not reach statistical significance (before vs. after: 3.1 ± 4.9 vs. −1.7 ± 3.2 mL/min/1.73 m 2 , respectively, P = 0.173, Fig. 1 B).

also in 111,027 other papers